P-glycoprotein-mediated transport of digitoxin, α-methyldigoxin and β-acetyldigoxin

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 3, 2001, Pages 337-343

  Pauli Magnus, Christiane ^a,b   Mürdter, Thomas ^b   Godel, Andrea ^b   Mettang, Thomas ^b   Eichelbaum, Michel ^b   Klotz, Ulrich ^b   Fromm, Martin F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Caco 2; Digitalis glycosides; Digoxin; P glycoprotein

Indexed keywords

ACETYLDIGOXIN; ALPHA METHYLDIGOXIN; CARDIAC GLYCOSIDE; DIGITOXIN; DIGOXIN; GLYCOPROTEIN P; UNCLASSIFIED DRUG; VALSPODAR;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TRANSPORT; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; TRANSPORT KINETICS;

ACETYLDIGOXINS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARDIOTONIC AGENTS; CYCLOSPORINS; DIGITOXIN; HUMANS; MEDIGOXIN; P-GLYCOPROTEIN;

EID: 0035118772     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000354     Document Type: Article

References (41)

1. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis
2. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
3. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs
4. Quinidine and digoxin. An important interaction
5. Digoxin and beta-methyldigoxin concentrations in cerebrospinal fluid and plasma
6. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells
7. Verteilungskoeffizienten und Rm-Werte von Cardenoliden
8. Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations
9. 86Rubidium uptake in erythrocytes
10. Evidence for the involvement of a distinct form of cytochrome P450 3A in the oxidation of digitoxin by rat liver microsomes
11. Phase I studie mit R-Verapamil zur aufhebung der multidrug-resistenz bei chemotherapie
12. Bioavailability of beta-acetyldigoxin and digoxin
13. β-Acetyldigoxin
14. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine
15. Comparison of bioavailability and enteral absorption of digoxin, beta-acetyldigoxin and beta-methyldigoxin. Measurement of cumulative renal excretion after a single application
16. The interaction of digoxin and rifampin: Role of intestinal P-glycoprotein
17. Radioimmunologic determination of glycosid concentrations in human brain tissue
18. Specific deuterium- and tritium exchange in cardanolides and cardanolide glycosides
19. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
20. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide
21. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
22. No advantages of acetyldigoxin and methyldigoxin compared to digoxin
23. Digitoxin intoxication during concomitant use of amiodarone
24. Enterale resorption und sekretion herzwirksamer glykoside
25. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein
26. Circumvention of multidrug resistance mediated by P-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma
27. Amiodarone-digoxin interaction: Clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications
28. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
29. Itraconazole increases serum digoxin concentration
30. Digoxin-verapamil interaction
31. Pharmacokinetic review of digitalis glycosides
32. A previously unrecognized drug interaction between quinidine and digoxin
33. Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses
34. The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics
35. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
36. Kardiaka
37. Interactions between digitoxin and some antiarrhythmic drugs
38. In vitro and in vivo modulation of multi-drug resistance with amiodarone
39. The digoxin-propafenone interaction: Characterization of a mechanism using renal tubular cell monolayers